• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM ULTRA PLUS XC TSK US; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM ULTRA PLUS XC TSK US; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94155
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pneumonia (2011)
Event Date 09/03/2021
Event Type  Injury  
Manufacturer Narrative
Clarification: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event of "pneumonia" is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of "pneumonia", deemed not device related is considered an unexpected adverse drug experience.
 
Event Description
Healthcare professional reporting injecting a patient with a syringe of juvederm® ultra plus xc in the lips and nasolabial fold.Six weeks later, patient was injected again with second syringe of juvederm® ultra xc in the lips and nasolabial fold.Two weeks later, patient experienced a "high fever" and "pneumonia," deemed not device related.No treatment has been provided.The event is ongoing.This is the same event and the same patient reported under mdr id# 3005113652-2021-03259 (allergan complaint #(b)(4)).This mdr is being submitted for the first injection, juvederm ultra plus xc.
 
Manufacturer Narrative
Additional, changed, and/or corrected data: b.2., b.5, h.6.
 
Event Description
Additional information reported the patient was hospitalized for the symptoms but unknown what treatment was provided.The event is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM ULTRA PLUS XC TSK US
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
MDR Report Key12527186
MDR Text Key273549205
Report Number3005113652-2021-03258
Device Sequence Number1
Product Code LMH
UDI-Device Identifier30888628000111
UDI-Public30888628000111
Combination Product (y/n)Y
PMA/PMN Number
P050047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 10/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2021
Device Catalogue Number94155
Device Lot NumberH30LA90533
Was Device Available for Evaluation? No
Date Manufacturer Received10/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
-
-